"We are pleased to report that all eight cohorts of our phase I first-in-human study of PRX-115, our recombinant uricase candidate being developed for the treatment of uncontrolled gout, are now ...

Michael Strahan breaks his silence after being deluged with hate from conservatives for not putting his hand on his heart ...